Nitisinone Arrests but Does Not Reverse Ochronosis in Alkaptonuric Mice.

CM Keenan, AJ Preston, H Sutherland, PJ Wilson, EE Psarelli, TF Cox, LR Ranganath, JC Jarvis, JA Gallagher

Research output: Contribution to journalArticlepeer-review

27 Citations (Scopus)

Abstract

Alkaptonuria (AKU) is an ultrarare autosomal recessive disorder resulting from a deficiency of homogentisate 1,2 dioxygenase (HGD), an enzyme involved in the catabolism of phenylalanine and tyrosine. Loss of HGD function prevents metabolism of homogentisic acid (HGA), leading to increased levels of plasma HGA and urinary excretion. Excess HGA becomes deposited in collagenous tissues and subsequently undergoes polymerisation, principally in the cartilages of loaded joints, in a process known as ochronosis. This results in an early-onset, devastating osteoarthropathy for which there is currently no effective treatment. We recently described the natural history of ochronosis in a murine model of AKU, demonstrating that deposition of ochronotic pigment begins very early in life and accumulates with age. Using this model, we were able to show that lifetime treatment with nitisinone, a potential therapy for AKU, was able to completely prevent deposition of ochronotic pigment. However, although nitisinone has been shown to inhibit ochronotic deposition, whether it can also facilitate removal of existing pigment has not yet been examined. We describe here that midlife administration of nitisinone to AKU mice arrests further deposition of ochronotic pigment in the tibiofemoral joint, but does not result in the clearance of existing pigment. We also demonstrate the dose-dependent response of plasma HGA to nitisinone, highlighting its efficacy for personalised medicine, where dosage can be tailored to the individual AKU patient.
Original languageEnglish
Pages (from-to)45-50
JournalJIMD Reports
Volume24
Early online date5 May 2015
DOIs
Publication statusPublished - 5 May 2015

Keywords

  • Tibial Plateau
  • Tibiofemoral Joint
  • Homogentistic Acid
  • Lifetime Treatment

Fingerprint

Dive into the research topics of 'Nitisinone Arrests but Does Not Reverse Ochronosis in Alkaptonuric Mice.'. Together they form a unique fingerprint.

Cite this